And 1 that isn’t….but probably should 1. There is a larger emphasis on clinical interpretation of sequencing data It’s now all about ‘big data’ since the decreasing cost of sequencing is not a major market restraint. In the long term, this is a restraint to watch. The bottle-neck is now shifting towards being able to […]
Archives for January 2016
and the results are in…. Over 100 people voted on their favorite piece of quantification equipment in my poll (see map above). As a recap on the differences for you between Nanodrop vs Qubit, you can read the article I wrote here. The results: Was this what you were expecting? Global trends If you have a […]
Here’s a few links to my favourite blog posts: The cost of a false-negative in molecular diagnostics How would the FDA bake a cake? By performance or design? Do your genes make you who you are? In review: Thanks all.